Tekla Healthcare Valuation
| HQH Stock | USD 18.80 0.10 0.53% |
At this time, the company appears to be undervalued. Tekla Healthcare Inv has a current Real Value of $21.54 per share. The regular price of the company is $18.8. Our model measures the value of Tekla Healthcare Inv from inspecting the company fundamentals such as Operating Margin of (0.01) %, shares outstanding of 50.62 M, and Return On Equity of 0.0734 as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Tekla Healthcare's valuation include:
Price Book 0.9485 | Enterprise Value 955.8 M | Price Sales 95.8741 | Trailing PE 14.4122 | Enterprise Value Revenue 12.8201 |
Undervalued
Today
Please note that Tekla Healthcare's price fluctuation is very steady at this time. Calculation of the real value of Tekla Healthcare Inv is based on 3 months time horizon. Increasing Tekla Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Tekla Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Tekla Stock. However, Tekla Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 18.8 | Real 21.54 | Hype 18.84 | Naive 18.98 |
The intrinsic value of Tekla Healthcare's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Tekla Healthcare's stock price.
Estimating the potential upside or downside of Tekla Healthcare Investors helps investors to forecast how Tekla stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Tekla Healthcare more accurately as focusing exclusively on Tekla Healthcare's fundamentals will not take into account other important factors: When choosing an evaluation method for Tekla Healthcare Inv, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Tekla Healthcare Cash |
|
Tekla Valuation Trend
Tekla Healthcare's real value analysis enables investors to forecast the earnings more efficiently. Using both Tekla Healthcare's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
Tekla Valuation Data Drivers
Tekla Healthcare Total Value Analysis
Tekla Healthcare Investors is currently projected to have company total value of 955.78 M with market capitalization of 955.8 M, debt of 1.15 M, and cash on hands of 62. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Tekla Healthcare fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
955.78 M | 955.8 M | 1.15 M | 62 |
Tekla Healthcare Investor Information
About 28.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.95. Some equities with similar Price to Book (P/B) outperform the market in the long run. Tekla Healthcare Inv last dividend was issued on the 23rd of August 2024. Based on the measurements of operating efficiency obtained from Tekla Healthcare's historical financial statements, Tekla Healthcare Investors is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in October.Tekla Healthcare Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Tekla signifies not a very effective usage of assets in September.Tekla Healthcare Ownership Allocation
Tekla Healthcare Inv shows a total of 50.62 Million outstanding shares. About 71.67 % of Tekla Healthcare outstanding shares are held by general public with 0.007 (%) owned by insiders and only 28.32 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Tekla Healthcare Profitability Analysis
The company reported the last year's revenue of 58.12 M. Total Income to common stockholders was 56.33 M with profit before taxes, overhead, and interest of 8.27 M.Tekla Healthcare Past Distributions to stockholders
About Tekla Healthcare Valuation
An absolute valuation paradigm, as applied to Tekla Stock, attempts to find the value of Tekla Healthcare Inv based on its fundamental and basic technical indicators. By analyzing Tekla Healthcare's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Tekla Healthcare's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Tekla Healthcare. We calculate exposure to Tekla Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Tekla Healthcare's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 66.8 M | 70.2 M | |
| Pretax Profit Margin | 1.11 | 1.06 | |
| Operating Profit Margin | 0.87 | 0.92 | |
| Net Profit Margin | 1.11 | 1.06 | |
| Gross Profit Margin | 0.73 | 0.74 |
A single share of Tekla Healthcare represents a small ownership stake in the entity. As a stockholder of Tekla, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Tekla Healthcare Dividends Analysis For Valuation
The Tekla Healthcare's current Dividends Paid is estimated to increase to about 37.7 M, while Dividend Yield is projected to decrease to 0.02. . The Tekla Healthcare's current Earnings Yield is estimated to increase to 0.09, while Retained Earnings are projected to decrease to under 5.1 M.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 35.9 M | 37.7 M | |
| Dividend Yield | 0.03 | 0.02 | |
| Dividend Payout Ratio | 0.13 | 0.10 | |
| Dividend Paid And Capex Coverage Ratio | (5.20) | (4.94) |
There are various types of dividends Tekla Healthcare can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Tekla shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Tekla Healthcare Investors directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Tekla pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Tekla Healthcare by the value of the dividends paid out.
Tekla Healthcare Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 49.4 M | |
| Quarterly Earnings Growth Y O Y | 0.145 |
Tekla Healthcare Current Valuation Indicators
Valuation refers to the process of determining the present value of Tekla Healthcare Investors and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Tekla we look at many different elements of the entity such as Tekla's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Tekla Healthcare's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Tekla Healthcare's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Tekla Healthcare, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Tekla Healthcare's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Tekla Healthcare's worth.Complementary Tools for Tekla Stock analysis
When running Tekla Healthcare's price analysis, check to measure Tekla Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tekla Healthcare is operating at the current time. Most of Tekla Healthcare's value examination focuses on studying past and present price action to predict the probability of Tekla Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tekla Healthcare's price. Additionally, you may evaluate how the addition of Tekla Healthcare to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |